Cathepsin S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate vein graft neointimal hyperplasia

Cardiovascular Research

Volumn 101, Issue 3, 2014, Pages 454-463

  Shi, Hong Tao ^a   Wang, Ying ^a   Jia, Li Xin ^a   Qin, Yan Wen ^a   Liu, Yan ^a   Li, Hui Hua ^a   Qi, Yong Fen ^a   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cathepsin S; Elastin; Hyperplasia; Neointima; Vein graft

Indexed keywords

CATHEPSIN S; ELASTIN; HYPERPLASIA; NEOINTIMA; VEIN GRAFT;

ANIMALS; CATHEPSINS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ELASTIC TISSUE; HYPERPLASIA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; SIGNAL TRANSDUCTION; VEINS;

EID: 84894552052     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt273     Document Type: Article

References (55)

1. Bourassa MG. Fate of venous grafts: the past, the present and the future. J AmColl Cardiol 1991;17:1081-1083.
2. Campeau L, Enjalbert M, Lesperance J, BourassaMG, Kwiterovich P Jr, Wacholder S et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-1332.
3. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43:742-751; discussion 751.
4. Kent KC, Liu B. Intimal hyperplasia-still here after all these years! Ann Vasc Surg 2004;18: 135-137.
5. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK. Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg 1992;15:708-716; discussion 716-707.
6. Muto A, Model L, Ziegler K, Eghbalieh SD, Dardik A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ J 2010;74:1501-1512.
7. Predel HG, Yang Z, von Segesser L, Turina M, Buhler FR, Luscher TF. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet 1992;340:878-879.
8. Wu X, Cheng J, Li P, Yang M, Qiu S, Liu P et al. Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts. Arterioscler Thromb Vasc Biol 2010;30:471-476.
9. Cheng J, Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler Thromb Vasc Biol 2007;27:1744-1751.
10. Cheng J, Wang Y, Ma Y, Chan BT, Yang M, Liang A et al. The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010;107:1265-1274.
11. Cheng J, Wang Y, Liang A, Jia L, Du J. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft. Circ Res 2012;110:230-240.
12. Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Luscher TF. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 1998;97:181-187.
13. Sharony R, Pintucci G, Saunders PC, Grossi EA, Baumann FG, Galloway AC et al. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and-2. Am J Physiol Heart Circ Physiol 2006;290: H1651-H1659.
14. Chang CJ, Chen CC, Hsu LA, Chang GJ, KoYH, ChenCFet al. Degradation of the internal elastic laminae in vein grafts of rats with aortocaval fistulae: potential impact on graft vasculopathy. Am J Pathol 2009;174:1837-1846.
15. Farand P, Garon A, Plante GE. Structure of large arteries: orientation of elastin in rabbit aortic internal elastic lamina and in the elastic lamellae of aortic media. Microvasc Res 2007;73:95-99.
16. Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005;96:368-375.
17. Morimoto M, Miyamoto S, Mizoguchi A, Kume N, Kita T, Hashimoto N. Mouse model of cerebral aneurysm: experimental induction by renal hypertension and local hemodynamic changes. Stroke 2002;33:1911-1915.
18. Indolfi C, Torella D, Coppola C, Stabile E, Esposito G, Curcio A et al. Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture. Am J Physiol Heart Circ Physiol 2002;283:H760-H767.
19. Bonan R, Paiement P, Scortichini D, Cloutier MJ, Leung TK. Coronary restenosis: evaluation of a restenosis injury index in a swine model. Am Heart J 1993;126:1334-1340.
20. O'Blenes SB, Zaidi SH, CheahAY, McIntyre B, Kaneda Y, Rabinovitch M. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration. Circulation 2000;102(19 Suppl 3):III289-III295.
21. Hance KA, Tataria M, Ziporin SJ, Lee JK, ThompsonRW. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kDa cell surface elastin receptor. J Vasc Surg 2002;35:254-261.
22. Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 2002;277: 44854-44863.
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
24. Thompson K, Kobayashi J, Childs T, Wigle D, Rabinovitch M. Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells inducing serine elastase activity via tyrosine kinase-mediated transcription and translation. J Cell Physiol 1998;174:78-89.
25. Campbell EJ, Silverman EK, Campbell MA. Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol 1989;143:2961-2968.
26. Liu J, Sukhova GK, Yang JT, Sun J, Ma L, RenAet al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 2006;184:302-311.
27. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583.
28. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1359-1366.
29. Sukhova GK, Shi GP. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? Ann N Y Acad Sci 2006;1085:161-169.
30. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-1197.
31. Bai L, Beckers L, Wijnands E, Lutgens SP, Her?́as MV, Saftig P et al. Cathepsin K gene disruption does not affect murine aneurysm formation. Atherosclerosis 2010;209:96-103.
32. Qin Y, Cao X, Guo J, Zhang Y, Pan L, Zhang H et al. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovasc Res 2012;96:401-410.
33. Zhang C, Li Y, Wu Y, Wang L, Wang X, DuJ. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 2013;288:1489-1499.
34. Qin Y, Cao X, Guo J, Zhang Y, Pan L, Zhang H et al. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovasc Res 2012;96:401-410.
35. Tang EH, Shvartz E, Shimizu K, Rocha VZ, Zheng C, Fukuda D et al. Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2011;31:261-269.
36. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, NaitoMet al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003;111: 897-906.
37. Li Y, Zhang C, Wu Y, Han Y, Cui W, Jia L et al. Interleukin-12p35 deletion promotesCD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-induced cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012;32:1662-1674.
38. Han YL, Li YL, Jia LX, Cheng JZ, Qi YF, Zhang HJ et al. Reciprocal interaction between macrophages andTcells stimulates IFN-gamma and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS One 2012;7:e35506.
39. Pan L, Li Y, Jia L, Qin Y, Qi G, Cheng J et al. Cathepsin S deficiency results in abnormal accumulation of autophagosomes in macrophages and enhances Ang II-induced cardiac inflammation. PLoS One 2012;7:e35315.
40. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Hayashi T, Song H et al. AT1 blockade attenuates atherosclerotic plaque destabilization accompanied by the suppression of cathepsin S activity in apoE-deficient mice. Atherosclerosis 2010;210:430-437.
41. Samokhin AO, Lythgo PA, Gauthier JY, Percival MD, Bromme D. Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe2/2 mice. J Cardiovasc Pharmacol 2010;56:98-105.
42. Schwartz RS, Henry TD. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 2002;3(Suppl 5):S4-S9.
43. Burns-Kurtis CL, Olzinski AR, Needle S, Fox JH, Capper EA, Kelly FM et al. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit. Cardiovasc Res 2004;62:610-620.
44. Oorni K, Sneck M, Bromme D, Pentikäinen MO, Lindstedt KA, Mäyränpää M et al. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem 2004;279:34776-34784.
45. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, BrissetteWHet al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006; 26:851-856.
46. Cheng XW, Kuzuya M, Nakamura K, Di Q, Liu Z, Sasaki T et al. Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol 2006;168:685-694.
47. Lindstedt L, Lee M, Oorni K, Bromme D, Kovanen PT. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem Biophys Res Commun 2003;312:1019-1024.
48. Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, Libby P et al. Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2011;31:2500-2508.
49. Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, Libby P et al. Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2012;32:15-23.
50. de Nooijer R, Bot I, von der Thusen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO et al. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb Vasc Biol 2009;29: 188-194.
51. Xin XQ, Gunesekera B, Mason RW. The specificity and elastinolytic activities of bovine cathepsins S and H. Arch Biochem Biophys 1992;299:334-339.
52. Novinec M, Grass RN, Stark WJ, Turk V, Baici A, Lenarcic B. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem 2007;282:7893-7902.
53. HuY, ZhangZ, Torsney E, Afzal AR, Davison F, Metzler B et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004;113:1258-1265.
54. Muto A, Yi T, Harrison KD, Dávalos A, Fancher TT, Ziegler KR et al. Eph-B4 prevents venous adaptive remodeling in the adult arterial environment. J Exp Med 2011;208: 561-575.
55. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301-1310.